BIORESTORATIVE THERAPIES, INC.: 10-K filed 2012-04-16
What BIORESTORATIVE THERAPIES, INC. reported in its annual report filed 2012-04-16 (fiscal FY 2011): 27 published measures, 70 facts as tagged in accession 0001144204-12-021914.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-04-16
- Fiscal period
- fiscal FY 2011
- Accession
- 0001144204-12-021914 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 220,973 | USD | |
| At 2010-12-31 | 468,506 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,907,370 | USD | |
| At 2010-12-31 | 1,212,728 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -3,686,397 | USD | |
| At 2010-12-31 | -744,222 | USD | |
| At 2009-12-31 | -51,087 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -4,073,937 | USD | 365 |
| 2009-01-01 to 2011-12-31 | -7,534,862 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | -2,263,799 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,197,126 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -2,810,867 | USD | 365 |
| 2009-01-01 to 2011-12-31 | -3,743,165 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | -729,218 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 17,772 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 163,243 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 45,383 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 2,850,073 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 3,949,592 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 796,034 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 14,228 | USD | 365 |
| 2009-01-01 to 2011-12-31 | -134,919 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | -48,784 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 94,827 | USD | |
| At 2010-12-31 | 446,756 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 456,826 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 2,282,151 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 895,608 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -3,552,005 | USD | 365 |
| 2009-01-01 to 2011-12-31 | -6,785,173 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | -2,069,337 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 118,423 | USD | |
| At 2010-12-31 | 18,074 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 260,011 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 288,498 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 24,155 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,907,370 | USD | |
| At 2010-12-31 | 1,015,852 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 426,184 | USD | |
| At 2010-12-31 | 160,187 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,000 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 32,000 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 28,000 | USD | 365 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,552,005 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 6,785,173 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 2,069,337 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 12,000 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 23,620 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 11,620 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 607,683,811 | shares | |
| At 2010-12-31 | 433,217,500 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,234,486 | USD | |
| At 2010-12-31 | 2,270,219 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,308 | USD | |
| At 2010-12-31 | 3,676 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 440,229 | USD | |
| At 2010-12-31 | 341,618 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 46,915 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,373,271 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 2,092,089 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 490,544 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 90,412 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 145,182 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 48,358 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -521,932 | USD | 365 |
| 2009-01-01 to 2011-12-31 | -749,689 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | -194,462 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 268,516 | USD | 365 |
| 2009-01-01 to 2011-12-31 | 368,703 | USD | 1095 |
| 2010-01-01 to 2010-12-31 | 81,918 | USD | 365 |
Inspect the source
- Entity
- BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
- Captured
- 2026-09-19T11:18:28.483Z
- SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))